title: The effect of adjuvant chemotherapy on stage IV (T4N1-3M0 and T1-3N3M0) gastric cancer.
abstract: OBJECTIVE
  The optimal chemotherapeutic strategy for gastric cancer patients has not been determined, especially with respect to stage and the curability of gastric cancer. The aim of this study was to evaluate the results of adjuvant chemotherapy on stage IV (T4N1-3M0 and T1-3N3M0) gastric cancer after curative gastrectomy between a chemotherapy (CTX) group and non-chemotherapy (non-CTX) group.
  
  
  METHODS
  Among 1,760 patients who underwent gastric surgery by 1 surgeon in a single institution, 162 stage IV gastric cancer patients with curative gastrectomy were analyzed retrospectively, excluding patients with TanyNanyM1. One hundred twenty-five patients who received different chemotherapeutic regimens were compared to 37 patients who did not receive chemotherapy for reasons of old age or according to their expressed desire.
  
  
  RESULTS
  The clinicopathologic factors which showed a clinically significant difference between the two groups were age and histology, which were not associated with patient survival. The CTX group was younger, and had a larger proportion of undifferentiated gastric cancers than the non-CTX group. The mode of treatment failure revealed no significant difference between the CTX and non-CTX groups. The 1, 3, and 5-year disease-free survival and the 1, 3, and 5-year disease-specific survival of the CTX group were 63.9%, 38.4%, and 32.0%, and 85.4%, 52.3%, and 39.6%, respectively, which were more favorable than the non-CTX group (p=0.015 and p=0.001, respectively). Postoperative adjuvant CTX was an independent risk factor for disease-specific survival of stage IV (T4N1-3M0 and T1-3N3M0) gastric cancer patients after curative gastrectomy by multivariate analysis (odds ratio=2.153; 95% confidence interval=1.349-3.435; p=0.001).
  
  
  CONCLUSIONS
  Adjuvant CTX may be associated with survival benefit for younger patients with stage IV (T4N1-3M0 and T1-3N3M0) gastric cancer with undifferentiated histology after curative gastrectomy. A randomized controlled trial to reveal the effect of stage-specific adjuvant chemotherapy should be conducted.
authors.affiliation: Department of Surgery, Hanyang University College of Medicine, Seoul, Korea.
authors.forename: Tae Kyung
authors.initials: TK
authors.lastname: Ha
authors.forename: Min Sung
authors.initials: MS
authors.lastname: Jung
authors.forename: Kang Hong
authors.initials: KH
authors.lastname: Lee
authors.forename: Kyeong Geun
authors.initials: KG
authors.lastname: Lee
authors.forename: Sung Joon
authors.initials: SJ
authors.lastname: Kwon
references.citation: Lancet Oncol. 2006 Jun;7(6):515-6
references.pmid: 16750502
references.citation: Am J Clin Oncol. 1982 Dec;5(6):649-55
references.pmid: 7165009
references.citation: Br J Cancer. 2001 Apr 6;84(7):878-80
references.pmid: 11286464
references.citation: Int J Cancer. 2004 May 1;109(5):737-41
references.pmid: 14999783
references.citation: Br J Surg. 2007 Dec;94(12):1468-76
references.pmid: 17948223
references.citation: J Clin Oncol. 2004 Aug 15;22(16):3408-19
references.pmid: 15199089
references.citation: Br J Surg. 1996 Feb;83(2):156-61
references.pmid: 8689153
references.citation: N Engl J Med. 2001 Sep 6;345(10):725-30
references.pmid: 11547741
references.citation: Tumori. 2002 Jan-Feb;88(1):21-7
references.pmid: 12004845
references.citation: N Engl J Med. 2006 Jul 6;355(1):11-20
references.pmid: 16822992
references.citation: J Natl Cancer Inst. 2008 Mar 19;100(6):388-98
references.pmid: 18334706
references.citation: Am Surg. 2007 Apr;73(4):359-66
references.pmid: 17439029
references.citation: Dis Colon Rectum. 2008 May;51(5):503-7
references.pmid: 18322753
references.citation: Ann Oncol. 2002 Feb;13(2):299-307
references.pmid: 11886009
references.citation: Ann Oncol. 2000 Jul;11(7):837-43
references.pmid: 10997811
references.citation: Eur J Surg Oncol. 2008 Nov;34(11):1208-16
references.pmid: 18353606
references.citation: CA Cancer J Clin. 1999 Jan-Feb;49(1):33-64, 1
references.pmid: 10200776
references.citation: Semin Surg Oncol. 2003;21(1):23-9
references.pmid: 12923913
references.citation: J Clin Oncol. 2003 Jun 15;21(12):2282-7
references.pmid: 12805327
references.citation: N Engl J Med. 2007 Nov 1;357(18):1810-20
references.pmid: 17978289
references.citation: J Clin Oncol. 1993 Aug;11(8):1441-7
references.pmid: 8336183
references.citation: Cancer Invest. 2008 Apr-May;26(3):317-25
references.pmid: 18317973